论文部分内容阅读
目的研究分析对于食管小细胞癌外科手术的治疗和预后情况。方法选择40例单纯行食管小细胞癌外科手术患者作为对照组,再选择同期40例行食管小细胞癌外科手术联合化疗患者作为观察组。对比分析两组患者在治疗后1、2、3年的生存率情况。结果观察组患者在治疗后1、2、3年的生存率明显高于对照组,其中2年生存率比较差异具有统计学意义(P<0.05)。有无淋巴结转移是影响患者预后的主要因素。结论对于食管小细胞癌患者采取外科治疗联合化疗具有更好的治疗效果,能够有效延长患者的生存期,值得临床推广。
Objective To analyze and analyze the treatment and prognosis of esophageal small cell carcinoma surgery. Methods Forty patients with simple small cell carcinoma of the esophagus were selected as the control group. Forty patients with esophageal squamous cell carcinoma combined with chemotherapy were selected as the observation group. Comparative analysis of two groups of patients after treatment 1, 2, 3 years survival rate. Results The survival rate of patients in observation group at 1, 2 and 3 years after treatment was significantly higher than that of control group, and the difference of 2-year survival rate was statistically significant (P <0.05). Whether lymph node metastasis is the main factor affecting the prognosis of patients. Conclusion For patients with esophageal small cell carcinoma, surgical treatment combined with chemotherapy has a better therapeutic effect, which can effectively prolong the survival of patients, it is worth clinical promotion.